{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:05:11Z","timestamp":1792188311996,"version":"4.4.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":1259,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003748","name":"Svenska S\u00e4llskapet f\u00f6r Medicinsk Forskning","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003748","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1038\/s41379-019-0252-6","type":"journal-article","created":{"date-parts":[[2019,3,28]],"date-time":"2019-03-28T08:21:58Z","timestamp":1553761318000},"page":"1082-1094","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Parafibromin immunostainings of parathyroid tumors in clinical routine: a near-decade experience from a tertiary center"],"prefix":"10.1016","volume":"32","author":[{"given":"C.Christofer","family":"Juhlin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inga-Lena","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Lagerstedt-Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Stenman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Br\u00e4nstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Tham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"H\u00f6\u00f6g","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/s41379-019-0252-6_bib1","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.jamcollsurg.2014.10.007","article-title":"Modern experience with aggressive parathyroid tumors in a high-volume New England referral center","volume":"220","author":"Quinn","year":"2015","journal-title":"J Am Coll Surg"},{"key":"10.1038\/s41379-019-0252-6_bib2","unstructured":"Bondeson L, Grimelius L, DeLellis RA, Lloyd R, \u00c5kerstr\u00f6m G, Larsson C, et al. Parathyroid carcinoma and parathyroid adenoma. In: DeLellis RA, Lloyd RV, Heitz PU, et al., editors. Pathology and genetics of tumours of endocrine organs. Lyon: International Agency for Research on Cancer Press, 2004. p. 124\u201332."},{"key":"10.1038\/s41379-019-0252-6_bib3","unstructured":"DeLellis RA, Arnold A, Bilezikian JP, Eng C, Larsson C, Lloyd RV, et al. Tumours of the parathyroid glands. In: Lloyd RV, Osamura RY, Kl\u00f6ppel G et al., editors. WHO classification of tumours of endocrine organs. Fourth edition. Lyon: International Agency for Research on Cancer, 2017. p. 146\u201358."},{"key":"10.1038\/s41379-019-0252-6_bib4","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/ng1048","article-title":"HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome","volume":"32","author":"Carpten","year":"2002","journal-title":"Nat Genet"},{"key":"10.1038\/s41379-019-0252-6_bib5","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1056\/NEJMoa031237","article-title":"Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma","volume":"349","author":"Shattuck","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1038\/s41379-019-0252-6_bib6","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1677\/ERC-07-0021","article-title":"Parafibromin immunoreactivity: its use as an additional diagnostic marker for parathyroid tumor classification","volume":"14","author":"Juhlin","year":"2007","journal-title":"Endocr Relat Cancer"},{"key":"10.1038\/s41379-019-0252-6_bib7","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1097\/01.pas.0000209827.39477.4f","article-title":"Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumor (HPT-JT) syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasias","volume":"30","author":"Gill","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-019-0252-6_bib8","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1677\/erc.1.01058","article-title":"Loss of parafibromin expression in a subset of parathyroid adenomas","volume":"13","author":"Juhlin","year":"2006","journal-title":"Endocr Relat Cancer"},{"key":"10.1038\/s41379-019-0252-6_bib9","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1530\/EJE-06-0720","article-title":"Should parafibromin staining replace HRTP2 gene analysis as an additional tool for histologic diagnosis of parathyroid carcinoma?","volume":"156","author":"Cetani","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"10.1038\/s41379-019-0252-6_bib10","doi-asserted-by":"crossref","first-page":"6629","DOI":"10.1158\/1078-0432.CCR-04-0493","article-title":"Loss of parafibromin immunoreactivity is a distinguishing feature of parathyroid carcinoma","volume":"10","author":"Tan","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1038\/s41379-019-0252-6_bib11","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/PAP.0b013e3181709f47","article-title":"Parafibromin as a tool for the diagnosis of parathyroid tumors","volume":"15","author":"Marcocci","year":"2008","journal-title":"Adv Anat Pathol"},{"key":"10.1038\/s41379-019-0252-6_bib12","doi-asserted-by":"crossref","first-page":"324964","DOI":"10.1155\/2010\/324964","article-title":"Parafibromin as a diagnostic instrument for parathyroid carcinoma-lone ranger or part of the posse?","volume":"2010","author":"Juhlin","year":"2010","journal-title":"Int J Endocrinol"},{"key":"10.1038\/s41379-019-0252-6_bib13","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1007\/s12020-016-0997-3","article-title":"Diagnostic performance of parafibromin immunohistochemical staining for sporadic parathyroid carcinoma: a meta-analysis","volume":"54","author":"Hu","year":"2016","journal-title":"Endocrine"},{"key":"10.1038\/s41379-019-0252-6_bib14","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s12022-010-9121-z","article-title":"Parafibromin and APC as screening markers for malignant potential in atypical parathyroid adenomas","volume":"21","author":"Juhlin","year":"2010","journal-title":"Endocr Pathol"},{"key":"10.1038\/s41379-019-0252-6_bib15","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1245\/s10434-013-3288-8","article-title":"Negative parafibromin staining predicts malignant behavior in atypical parathyroid adenomas","volume":"21","author":"Kruijff","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1038\/s41379-019-0252-6_bib16","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/nar\/gkp991","article-title":"The tumor suppressor, parafibromin, mediates histone H3 K9 methylation for cyclin D1 repression","volume":"38","author":"Yang","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"10.1038\/s41379-019-0252-6_bib17","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/sj.onc.1208274","article-title":"Parafibromin, product of the hyperparathyroidism-jaw tumor syndrome gene HRPT2, regulates cyclin D1\/PRAD1 expression","volume":"24","author":"Woodard","year":"2005","journal-title":"Oncogene"},{"key":"10.1038\/s41379-019-0252-6_bib18","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.molcel.2011.05.014","article-title":"SHP2 tyrosine phosphatase converts parafibromin\/Cdc73 from a tumor suppressor to an oncogenic driver","volume":"43","author":"Takahashi","year":"2011","journal-title":"Mol Cell"},{"key":"10.1038\/s41379-019-0252-6_bib19","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.cell.2006.01.053","article-title":"Parafibromin\/Hyrax activates Wnt\/Wg target gene transcription by direct association with beta-catenin\/Armadillo","volume":"125","author":"Mosimann","year":"2006","journal-title":"Cell"},{"key":"10.1038\/s41379-019-0252-6_bib20","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12887","article-title":"Dephosphorylated parafibromin is a transcriptional coactivator of the Wnt\/Hedgehog\/Notch pathways","volume":"7","author":"Kikuchi","year":"2016","journal-title":"Nat Commun"},{"key":"10.1038\/s41379-019-0252-6_bib21","first-page":"481","article-title":"Loss of expression for the Wnt pathway components adenomatous polyposis coli and glycogen synthase kinase 3-beta in parathyroid carcinomas","volume":"34","author":"Juhlin","year":"2009","journal-title":"Int J Oncol"},{"key":"10.1038\/s41379-019-0252-6_bib22","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/modpathol.2010.236","article-title":"Downregulation of CASR expression and global loss of parafibromin staining are strong negative determinants of prognosis in parathyroid carcinoma","volume":"24","author":"Witteveen","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-019-0252-6_bib23","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1007\/s00268-014-2700-2","article-title":"Parafibromin, galectin-3, PGP9.5, Ki67, and cyclin D1: using an immunohistochemical panel to aid in the diagnosis of parathyroid cancer","volume":"38","author":"Truran","year":"2014","journal-title":"World J Surg"},{"key":"10.1038\/s41379-019-0252-6_bib24","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1097\/PAI.0000000000000378","article-title":"Parafibromin, APC, and MIB-1 are useful markers for distinguishing parathyroid carcinomas from adenomas","volume":"25","author":"Hosny Mohammed","year":"2017","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1038\/s41379-019-0252-6_bib25","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1210\/jc.2008-1740","article-title":"Accuracy of combined protein gene product 9.5 and parafibromin markers for immunohistochemical diagnosis of parathyroid carcinoma","volume":"94","author":"Howell","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/s41379-019-0252-6_bib26","doi-asserted-by":"crossref","first-page":"e9472","DOI":"10.1371\/journal.pone.0009472","article-title":"Frequent promoter hypermethylation of the APC and RASSF1A tumour suppressors in parathyroid tumours","volume":"5","author":"Juhlin","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1038\/s41379-019-0252-6_bib27","doi-asserted-by":"crossref","DOI":"10.1186\/1476-4598-9-294","article-title":"Aberrant WNT\/\u03b2-catenin signaling in parathyroid carcinoma","volume":"9","author":"Svedlund","year":"2010","journal-title":"Mol Cancer"},{"key":"10.1038\/s41379-019-0252-6_bib28","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1136\/jcp.2005.029017","article-title":"Worrisome histologic alterations following fine-needle aspiration of the parathyroid","volume":"59","author":"Alwaheeb","year":"2006","journal-title":"J Clin Pathol"},{"key":"10.1038\/s41379-019-0252-6_bib29","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40463-016-0178-7","article-title":"The dangers of parathyroid biopsy","volume":"46","author":"Kim","year":"2017","journal-title":"J Otolaryngol Head Neck Surg"},{"key":"10.1038\/s41379-019-0252-6_bib30","doi-asserted-by":"crossref","first-page":"5070","DOI":"10.1016\/j.febslet.2007.09.050","article-title":"Nucleolar localization of parafibromin is mediated by three nucleolar localization signals","volume":"581","author":"Hahn","year":"2007","journal-title":"FEBS Lett"},{"key":"10.1038\/s41379-019-0252-6_bib31","doi-asserted-by":"crossref","first-page":"e97994","DOI":"10.1371\/journal.pone.0097994","article-title":"Characterization of a new CDC73 missense mutation that impairs Parafibromin expression and nucleolar localization","volume":"9","author":"Masi","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1038\/s41379-019-0252-6_bib32","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1677\/ERC-09-0272","article-title":"Defective nucleolar localization and dominant interfering properties of a parafibromin L95P missense mutant causing the hyperparathyroidism-jaw tumor syndrome","volume":"17","author":"Panicker","year":"2010","journal-title":"Endocr Relat Cancer"},{"key":"10.1038\/s41379-019-0252-6_bib33","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00428-010-1032-3","article-title":"Absence of nucleolar parafibromin immunoreactivity in subsets of parathyroid malignant tumours","volume":"459","author":"Juhlin","year":"2011","journal-title":"Virchows Arch"},{"key":"10.1038\/s41379-019-0252-6_bib34","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s12022-013-9294-3","article-title":"Understanding the genetic basis of parathyroid carcinoma","volume":"25","author":"Gill","year":"2014","journal-title":"Endocr Pathol"},{"key":"10.1038\/s41379-019-0252-6_bib35","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/PAS.0000000000001017","article-title":"Parafibromin-deficient (HPT-JT Type, CDC73 mutated) parathyroid tumors demonstrate distinctive morphologic features","volume":"43","author":"Gill","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-019-0252-6_bib36","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s13402-012-0100-x","article-title":"CDC73 mutations and parafibromin immunohistochemistry in parathyroid tumors: clinical correlations in a single-centre patient cohort","volume":"35","author":"Guarnieri","year":"2012","journal-title":"Cell Oncol (Dordr)"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41379-019-0252-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41379-019-0252-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222010262?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222010262?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41379-019-0252-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:43:58Z","timestamp":1760229838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222010262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S0893395222010262"],"URL":"https:\/\/doi.org\/10.1038\/s41379-019-0252-6","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Parafibromin immunostainings of parathyroid tumors in clinical routine: a near-decade experience from a tertiary center","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/s41379-019-0252-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}